Vita Life Sciences Ltd (VLS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$6.60 Million ≈ $4.67 Million USD) by net assets (AU$52.62 Million ≈ $37.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Vita Life Sciences Ltd for the company's overall valuation and market capitalisation.

Vita Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Vita Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vita Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vita Life Sciences Ltd ranked by their cash flow conversion efficiency. Explore VLS cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sunfon Construction Co Ltd TWO:5514	-0.113x
Devsisters corporation KQ:194480	-0.092x
Eva Live Inc. Common Stock NASDAQ:GOAI	-0.231x
Aurora World Corporation KQ:039830	0.111x
Riverview Bancorp Inc NASDAQ:RVSB	-0.024x
Yi Jinn Industrial Co Ltd TW:1457	0.020x
LINMON MEDIA LTD -000025 F:8MN	N/A
SBI Investment KOREA Co. Ltd KQ:019550	-0.020x

Annual Cash Flow Conversion Efficiency for Vita Life Sciences Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Vita Life Sciences Ltd from 2006 to 2024. View VLS share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$52.28 Million ≈ $36.99 Million	AU$6.16 Million ≈ $4.36 Million	0.118x	-60.71%
2023-12-31	AU$43.33 Million ≈ $30.66 Million	AU$12.98 Million ≈ $9.19 Million	0.300x	+294.10%
2022-12-31	AU$36.50 Million ≈ $25.83 Million	AU$2.77 Million ≈ $1.96 Million	0.076x	-60.73%
2021-12-31	AU$30.42 Million ≈ $21.53 Million	AU$5.89 Million ≈ $4.17 Million	0.194x	-37.28%
2020-12-31	AU$24.44 Million ≈ $17.29 Million	AU$7.54 Million ≈ $5.34 Million	0.309x	+242.94%
2019-12-31	AU$22.53 Million ≈ $15.94 Million	AU$2.03 Million ≈ $1.43 Million	0.090x	-29.04%
2018-12-31	AU$22.41 Million ≈ $15.85 Million	AU$2.84 Million ≈ $2.01 Million	0.127x	-2.28%
2017-12-31	AU$24.79 Million ≈ $17.54 Million	AU$3.22 Million ≈ $2.28 Million	0.130x	-36.14%
2016-12-31	AU$23.18 Million ≈ $16.40 Million	AU$4.71 Million ≈ $3.33 Million	0.203x	-5.56%
2015-12-31	AU$22.88 Million ≈ $16.19 Million	AU$4.92 Million ≈ $3.48 Million	0.215x	-24.11%
2014-12-31	AU$21.57 Million ≈ $15.26 Million	AU$6.12 Million ≈ $4.33 Million	0.284x	-4.59%
2013-12-31	AU$16.27 Million ≈ $11.51 Million	AU$4.83 Million ≈ $3.42 Million	0.297x	+143.73%
2012-12-31	AU$11.34 Million ≈ $8.03 Million	AU$1.38 Million ≈ $978.56K	0.122x	-80.71%
2011-12-31	AU$8.96 Million ≈ $6.34 Million	AU$5.66 Million ≈ $4.01 Million	0.632x	+712.81%
2010-12-31	AU$8.13 Million ≈ $5.75 Million	AU$-838.65K ≈ $-593.40K	-0.103x	+83.17%
2009-12-31	AU$3.90 Million ≈ $2.76 Million	AU$-2.39 Million ≈ $-1.69 Million	-0.613x	-515.31%
2008-12-31	AU$3.85 Million ≈ $2.72 Million	AU$567.42K ≈ $401.48K	0.148x	-43.35%
2007-12-31	AU$2.88 Million ≈ $2.04 Million	AU$750.00K ≈ $530.67K	0.260x	+68.96%
2006-12-31	AU$3.35 Million ≈ $2.37 Million	AU$516.00K ≈ $365.10K	0.154x	--

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$107.05 Million

AU$151.30 Million AUD

Market Cap Rank

#19041 Global

#605 in Australia

Share Price

AU$2.77

Change (1 day)

+2.21%

52-Week Range

AU$2.27 - AU$2.83

All Time High

AU$2.83